Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations

Benjamin G. Bitler, Katherine M. Aird, Rugang Zhang

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The components of the Switch/Sucrose non-fermentable (SWI/SNF) complex are mutated in approximately 20% of human cancers. The A/T-rich interacting domain 1A (ARID1A) subunit has one of the highest mutation rates. Most notably, ARID1A is mutated in over 50% of ovarian clear cell carcinomas (OCCCs). We reported that inhibition of enhancer of zeste homology 2 (EZH2) is synthetically lethal in ARID1A-mutated OCCC.

Original languageEnglish (US)
Article numbere1032476
JournalMolecular and Cellular Oncology
Volume3
Issue number1
DOIs
Publication statusPublished - Jan 2 2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Cancer Research

Cite this